These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 2975124)
1. [Comparative effectiveness of the combined use of fenazepam, haloperidol, lithium and metabolic preparations in treating the psychopathologic disorders with obsessions in slowly progressive schizophrenia]. Kadysheva NM; Mokhovikov AN; Mosketi KV; Kryzhanovskiĭ GN Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(10):88-92. PubMed ID: 2975124 [TBL] [Abstract][Full Text] [Related]
2. [Complex use of phenazepam, lithium and haloperidol in the treatment of several forms of schizophrenia]. Mosketi KV; Mokhovikov AN; Aksent'ev SB; Goĭkhberg IG; Kryzhanovskiĭ GN Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(4):589-96. PubMed ID: 6730829 [TBL] [Abstract][Full Text] [Related]
3. Lithium combined with haloperidol in schizophrenic patients. Lerner Y; Mintzer Y; Schestatzky M Br J Psychiatry; 1988 Sep; 153():359-62. PubMed ID: 3150693 [TBL] [Abstract][Full Text] [Related]
4. [Structure of the anxious-delusional syndrome of schizophrenic patients during treatment with anxiolytics]. Vasil'ev AA; Nuller IuL Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(8):1217-22. PubMed ID: 2877531 [TBL] [Abstract][Full Text] [Related]
5. [Experience in using fenazepam to treat psychotic patients]. Nuller IuL; Tochilov VA Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(6):914-20. PubMed ID: 6106340 [TBL] [Abstract][Full Text] [Related]
6. [Relation between the effect of tranquilizers and various features of personality structure among patients with borderline states]. Aleksandrovskiĭ IuA; Khrulenko-Varnitskiĭ IO; Uvarova LG Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(9):1367-76. PubMed ID: 6506985 [TBL] [Abstract][Full Text] [Related]
7. [Complex use of benzodiazepines, lithium salts and haloperidol in the treatment of obsessive movements and tics of different origin]. Aksent'ev SB; Borisova NP; Levinskiĭ MV; Kryzhanovskiĭ GN Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(3):432-7. PubMed ID: 2883793 [TBL] [Abstract][Full Text] [Related]
8. [Relation between the dynamics of EEG indices after a single dose of the tranquilizer phenazepam and its efficacy during a course of treatment of patients with borderline neuropsychological disorders]. Uvarova LG; Titaeva MA Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(11):1701-9. PubMed ID: 4082841 [TBL] [Abstract][Full Text] [Related]
9. [Successful combined neuroleptic and lithium treatment of a chronic schizophrenic patient with recurrent aggressive behavior]. Cabrera JF; Körner W; Müller-Oerlinghausen B Nervenarzt; 1986 Jun; 57(6):366-9. PubMed ID: 3736728 [No Abstract] [Full Text] [Related]
10. [Clinico-pharmacologic analysis neurovegetotropic activity of tranquilizers]. Aleksandrovskiĭ IuA; Ben'kovich BI Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(5):743-50. PubMed ID: 6464592 [TBL] [Abstract][Full Text] [Related]
11. To the incompatibility of haloperidol with lithium salts. Marhold J; Zimanová J; Lachman M; Král J; Vojtĕchovský M Act Nerv Super (Praha); 1974 Aug; 16(3):199-200. PubMed ID: 4420744 [No Abstract] [Full Text] [Related]
12. Drugs for psychiatric disorders. Med Lett Drugs Ther; 1976 Oct; 18(22):89-96. PubMed ID: 10519 [No Abstract] [Full Text] [Related]
13. Beneficial effects of ondansetron as an adjunct to haloperidol for chronic, treatment-resistant schizophrenia: a double-blind, randomized, placebo-controlled study. Zhang ZJ; Kang WH; Li Q; Wang XY; Yao SM; Ma AQ Schizophr Res; 2006 Dec; 88(1-3):102-10. PubMed ID: 16959472 [TBL] [Abstract][Full Text] [Related]
14. [Effect of vitamin preparations on epileptic activity]. Kryzhanovskiĭ GN; Shandra AA; Godlevskiĭ LS Biull Eksp Biol Med; 1984 Aug; 98(8):150-3. PubMed ID: 6235864 [TBL] [Abstract][Full Text] [Related]
15. [The effect of endovascular laser therapy and antioxidants on the immune status and energy metabolism of patients with treatment-resistant forms of schizophrenia]. Kut'ko II; Frolov VM; Pustovoĭ IuG; Pavlenko VV; Rachkauskas GS Zh Nevrol Psikhiatr Im S S Korsakova; 1996; 96(2):34-8. PubMed ID: 8754337 [TBL] [Abstract][Full Text] [Related]
16. [The efficacy of quercetin and tocopherol acetate in treating patients with Flexner's dysentery]. Frolov VM; Peresadin NA; Khomutianskaia NI; Pshenichnyĭ IIa Lik Sprava; 1993 Apr; (4):84-6. PubMed ID: 8209460 [TBL] [Abstract][Full Text] [Related]
17. Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia or schizoaffective disorder: a double-blind, placebo-controlled comparison with intramuscular haloperidol. Andrezina R; Josiassen RC; Marcus RN; Oren DA; Manos G; Stock E; Carson WH; Iwamoto T Psychopharmacology (Berl); 2006 Oct; 188(3):281-92. PubMed ID: 16953381 [TBL] [Abstract][Full Text] [Related]
18. Short-term treatment with risperidone or haloperidol in first-episode schizophrenia: 8-week results of a randomized controlled trial within the German Research Network on Schizophrenia. Möller HJ; Riedel M; Jäger M; Wickelmaier F; Maier W; Kühn KU; Buchkremer G; Heuser I; Klosterkötter J; Gastpar M; Braus DF; Schlösser R; Schneider F; Ohmann C; Riesbeck M; Gaebel W Int J Neuropsychopharmacol; 2008 Nov; 11(7):985-97. PubMed ID: 18466670 [TBL] [Abstract][Full Text] [Related]
19. [The therapeutic efficacy and the effect of gidazepam and fenazepam on the psychophysiological status and on the performance of operators with mental disorders at a neurotic level]. Neznamov GG; Morozov IS; Barchukov VG; Teleshova ES; Siuniakov SA; Zhirov EN; Tkachev AE; Belyĭ IuN; Kolotilinskaia NV; Safarova TP; Barannikov AS; Chernyĭ AV; Shestopalov SS Eksp Klin Farmakol; 1997; 60(4):17-21. PubMed ID: 9376749 [TBL] [Abstract][Full Text] [Related]